跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BETEFLAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BETEFLAM
Authorized
STANDARD
BETEFLAM
IBSA Institut Biochimique SA
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
11f2eb52514272d1
Company
IBSA Institut Biochimique SA
Type
Standard
Approval Details
Approval Id
11f2eb52514272d1
Drug Approval Canada Name
BETEFLAM
Product Name
BETEFLAM
Status
Cancelled Post Market
Status Date
2024-06-24
Original Market Date
2016-04-05
Din
02449773
Drug Class
Human
Dosage Form
Patch
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:06.00
Atc Original
D07AC01 BETAMETHASONE
Atc Name
d 07 ac 01
Aig Number
0106302001
Company Name
IBSA Institut Biochimique SA
Company Address
Via Pian Scairolo 49, Pazzallo, --, Switzerland, 6912
Company Detail Path
/organization/ibsa-institut-biochimique-sa
Company Information
Pharmaceutical Company Name
IBSA Institut Biochimique SA
Name Zh
IBSA生化研究所有限公司
Country Name
Netherlands
Province Name
Gelderland
City Name
arnhem,gelderland,country_nl
Address
Velperplein 23
Website
http://www.ibsagroup.com
Active Ingredients
BETAMETHASONE VALERATE
0.1 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
11f2eb52514272d1
Type
Standard
Back to Health Canada Approvals